ELIGLUSTAT | ELIGLUSTAT | ATC A16AX10
METABOLISM A GLUCOSYLCERAMIDE SYNTHASE INHIBITOR LONG-TERM TREATMENT OF ADULT PATIENTS WITH GAUCHER DISEASE TYPE 1 RESEMBLES THE CERAMIDE SUBSTRATE | ORAL | Cmax 339 NANOMOLAR Tmax 3 HOUR VD 835 LITER PPB 79.5 PERCENT Cl 88 LITER / HOUR HT 8.9 HOUR | GLUCOSYLCERAMIDE SYNTHASE | CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR CHEMBL2063 CERAMIDE GLUCOSYLTRANSFERASE Q16739 CERAMIDE GLUCOSYLTRANSFERASE HOMO SAPIENS ENZYME TRANSFERASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |